Risperidone solid dispersion for orally disintegrating tablet: Its formulation design and non-destructive methods of evaluation

International Journal of Pharmaceutics

Volumn 400, Issue 1-2, 2010, Pages 49-58

  Rahman, Ziyaur ^a   Zidan, Ahmed S ^a   Khan, Mansoor A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Methyl cyclodextrin; Orally disintegrating tablet; Risperidone; Solid dispersion

Indexed keywords

METHYL BETA CYCLODEXTRIN; RISPERIDONE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; NEAR INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TABLET DISINTEGRATION; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; EXCIPIENTS; MICROSCOPY, ELECTRON, SCANNING; RISPERIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTROSCOPY, NEAR-INFRARED; TABLETS; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 77957656680     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.08.025     Document Type: Article

References (50)

1. Ahmed I., Aboul-Einien M. In vitro and in vivo evaluation of a fast disintegrating lyophlised dry emulsion tablet containing griseofulvin. Eur. J. Pharm. Sci. 2007, 32:58-68.
2. Alcala M., Blanco M., Bautista M., González J.M. On-line monitoring of a granulation process by NIR spectroscopy. J. Pharm. Sci. 2009, 99:336-345.
3. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. A theoretical basis for biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12:413-420.
4. Babu R.J., Dayal P., Singh M. Effect of cyclodextrins on the complexation and nasal permeation of melatonin. Drug Deliv. 2008, 15:381-388.
5. Baratieri S.C., Barbosa J.M., Freitas M.P., Martins J.A. Multivariate analysis of nystatin and metronidazole in a semi-solid matrix by means of diffuse reflectance NIR spectroscopy and PLS regression. J. Pharm. Biomed. Anal. 2006, 40:51-55.
6. Barnes R.J., Dhanoa M.S., Lister S.J. Standard normal variate transformation and de-trending of near-infrared diffuse reflectance spectra. Appl. Spectrosc. 1989, 43:772-777.
7. Biradar S.S., Bhagavaati S.T., Kuppasad I.J. Fast dissolving drug delivery systems: a brief overview. Int. J. Pharmacol. 2006, 4.
8. Brewster M.E., Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 2007, 59:645-666.
9. Chen R., Takahashi H., Okamoto H., Danjo K. Particle design of three-component system for sustained release using a 4-fluid nozzle spray-drying technique. Chem. Pharm. Bull. (Tokyo) 2006, 54:1486-1490.
10. Cirri M., Maestrelli F., Mennini N., Mura P. Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems. J. Pharm. Biomed. Anal. 2009, 50:690-694.
11. Corveleyn S., Remon J. Formulation of a lyophilised dry emulsion tablet for the delivery of poorly soluble drugs. Int. J. Pham. 1998, 166:65-74.
12. 1H NMR spectroscopy. J. Chromatogr. A 2008, 1215:185-193.
13. Dhopeshwarker V., Kowal R., Mattes R.A., Randolph W., Schroeder R. Monitoring granulation drying using near-infrared spectroscopy. Pharm. Tech. Eur. 2005, 17:41-45.
14. El-Arini S.K., Clas S.D Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer. Pharm. Dev. Tech. 2002, 7:361-371.
15. Food and Drug Administration - Guidance for Industry - Orally Disintegrating Tablet. Silver Spring, Maryland, USA, 2008.
16. Geladi P., MacDougall D., Martens H. Linearization and scatter-correction for near-infrared reflectance spectra of meat. Appl. Spectrosc. 1985, 39:491-500.
17. Gendrin C., Roggo Y., Spiegel C., Collet C. Monitoring galenical process development by near infrared chemical imaging: one case study. Eur. J. Pharm. Biopharm. 2008, 68:828-837.
18. Ghorab M.M., Abdel-Salam H.M., El-Sayad M.A., Mekhel M.M. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech 2004, 5:e59.
19. Heigl N., Petter C.H., Lieb M., Bonn G.K., Huck C.W. Near-infrared reflection spectroscopy and partial least squares regression for determining the total carbon coverage of silica packings for liquid chromatography. Vib. Spectrosc. 2009, 49:155-161.
20. http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm (accessed on April 01, 2010).
21. International Conference of Harmonization-Validation of Analytical Procedures Q2(R1), 2005.
22. Kanagale P., Patel V., Venkatesan N., Jain M., Patel P., Misra A. Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine. Curr. Drug Deliv. 2008, 5:306-311.
23. Khan M.A., Karnachi A.A., Agarwal V., Vaithiyalingam S.V., Nazzal S., Reddy I.K. Stability characterization of controlled release coprecipitates and solid dispersions. J. Control. Release 2000, 63:1-6.
24. Klein S., Wempe M.F., Zoeller T., Buchanan N.L., Lambert J.L., Ramsey M.G., Edgar K.J., Buchanan C.M. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin. J. Pharm. Pharmacol. 2009, 61:23-30.
25. LaPlant F. Factors affecting NIR chemical images of solid dosage forms. Am. Pharm. Rev. 2004, 7:16-24.
26. Li W., Bagno l.L., Berman M., Chiarella R.A., Gerber M. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis. Int. J. Pharm. 2009, 380:49-54.
27. Liu C., Zhu S.J., Zhou Y., Wei Y.P., Pei Y.Y. Enhancement of dissolution of cyclosporine A using solid dispersions with polyoxyethylene (40) stearate. Pharmazie 2006, 61:681-684.
28. Mannila J., Järvinen T., Järvinen K., Jarho P. Precipitation complexation method produces cannabidiol/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol. J Pharm Sci 2007, 96(2):312-321.
29. Mathot F., van Beijsterveldt L., Preat V., Brewster M., Arien A. Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J. Control. Release 2006, 111:47-55.
30. Mizumoto T., Masuda Y., Yamamoto T., Yonemochi E., Terada K. Formulation design of a novel fast-disintegrating tablet. Int. J. Pharm. 2005, 306:83-90.
31. Patel A.R., Vavia1 P.R. Preparation and evaluation of taste masked famotidine formulation using drug/β-cyclodextrin/polymer ternary complexation approach. AAPS PharmSciTech 2008, 9:544-550.
32. Puchert T., Lochmann D., Menezes J.C., Reich G. Near-infrared chemical imaging (NIR-CI) for counterfeit drug identification-a four-stage concept with a novel approach of data processing (Linear Image Signature). J. Pharm. Biomed. Anal. 2010, 51:138-145.
33. Quadir A., Kolter K. A comparative study of current superdisintegrants. Pharm. Technol. 2006, (October).
34. Rahman Z., Kohli K., Khar R.K., Ali M., Charoo N.A., Shamsher N.A. Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech 2006, 7:E1-E9.
35. Rahman Z., Zidan A.S., Habib M.J., Khan M.A. Formulation and evaluation of a protein loaded solid dispersions by non-destructive methods. AAPS J. 2010, 12:158-170.
36. Rahman Z., Zidan A.S., Habib M.J., Khan M.A. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 2010, (May 12 Epub).
37. Rahamathulla M., Hv G., Rathod N. Solubility and dissolution improvement of rofecoxib using solid dispersion technique. Pak. J. Pharm. Sci. 2008, 21:350-355.
38. Rantanen J., Wikström H., Turner R., Taylor L.S. Use of in-line near-infrared spectroscopy in combination with chemometrics for improved understanding of pharmaceutical processes. Anal. Chem. 2005, 77:556-563.
39. Ryan J.A., Compton S.V., Brooks M.A., Compton D.A. Rapid verification of identity and content of drug formulations using mid-infrared spectroscopy. J. Pharm. Biomed. Anal. 1991, 9:303-310.
40. Sekulic S.S., Ward H.W., Brannegan D.R., Stanley E.D., Evans C.L., Sciavolino S.T., Hailey P.A., Aldridge P.K. On-line monitoring of powder blend homogeneity by near-infrared spectroscopy. Anal. Chem. 1996, 68:509-513.
41. Smith R.C., Baker K.S. Optical properties of clearest natural waters (200-800nm). Appl. Opt. 1981, 20:177-184.
42. Suda M., Takayama K., Otsuka M. An accurate quantitative analysis of polymorphic content by chemometric X-ray powder diffraction. Anal. Sci. 2008, 24:451-457.
43. Sulub Y., Wabuyele B., Gargiulo P., Pazdan J., Cheney J., Berry J., Gupta A., Shah R., Wu H., Khan M.A. Real-time on-line blend uniformity monitoring using near-infrared reflectance spectrometry: a noninvasive off-line calibration approach. J. Pharm. Biomed. Anal. 2009, 49:48-54.
44. Suthar A.P., Dubey S.A., Patel S.R., Shah A.M. Determination of risperidone and forced degradation behavior by HPLC in tablet dosage form. Int. J. PharmTech. Res. 2009, 1:568-574.
45. Tahboub Y.R., Pardue H.L. Evaluation of multiwavelength first- and second-derivative spectra for the quantitation of mixtures of polynuclear aromatic hydrocarbons. Anal. Chem. 1985, 57:38-41.
46. Tewes F., Brillault J., Couet W., Olivier J.C. Formulation of rifampicin-cyclodextrin complexes for lung nebulization. J. Control. Release 2008, 129:93-99.
47. USP-32-NF-27 Risperidone Tablet 3519, 2009. Rockville, Maryland, United States.
48. USP-32-NF-27 Uniformity of Dosage Unit (905) 382, 2009. Rockville, Maryland, United States.
49. Wang S., Ding Y., Yao Y. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Drug Dev. Ind. Pharm. 2009, 31:1-6.
50. Zidan A.S., Rahman Z., Habib M.J., Khan M.A. Spectral and spatial characterization of protein loaded PLGA nanoparticles. J. Pharm. Sci. 2010, 99:1180-1192.